Napredna pretraga

Pregled bibliografske jedinice broj: 603264

Croatian project on early detection of Alzheimer´s disease : Preliminary findings


Šimić, Goran; Babić, Mirjana; Bažadona, Danira; Borovečki, Fran; Hajnšek, Sanja; Henigsberg, Neven; Jazvinšćak-Jembrek, Maja; Jovanov- Milošević, Nataša; Kalanj-Bognar, Svjetlana; Mustapić, Maja et al.
Croatian project on early detection of Alzheimer´s disease : Preliminary findings // 8th FENS Forum of Neuroscience ; u: FENS Abstract 6 (2012) ; p013.31 / FENS (ur.).
Barcelona: FENS, 2012. str. 31-31 (poster, međunarodna recenzija, sažetak, znanstveni)


Naslov
Croatian project on early detection of Alzheimer´s disease : Preliminary findings

Autori
Šimić, Goran ; Babić, Mirjana ; Bažadona, Danira ; Borovečki, Fran ; Hajnšek, Sanja ; Henigsberg, Neven ; Jazvinšćak-Jembrek, Maja ; Jovanov- Milošević, Nataša ; Kalanj-Bognar, Svjetlana ; Mustapić, Maja ; Mimica, Ninoslav ; Mueck-Šeler, Dorotea ; Nedić, Gordana ; Nikolac, Matea ; Petrović, Ratimir ; Pivac, Nela ; Presečki, Paola ; Radoš, Milan ; Stanić, Gabrijela ; Švob-Štrac, Dubravka ; Vukelić, Željka ; Hof, Patrick

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
8th FENS Forum of Neuroscience ; u: FENS Abstract 6 (2012) ; p013.31 / FENS - Barcelona : FENS, 2012, 31-31

Skup
FENS Forum of Neuroscience (8 ; 2012)

Mjesto i datum
Barcelona, Španjolska, 14.-18.07.2012

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Alzheimer's disease; behavioral and psychological symptoms of dementia; beta-amyloid; cerebrospinal fluid; genomic profiling; mild cognitive impairment; monoaminergic systems; magnetic resonance imaging; proteomics; tau protein
(Alzheimer's disease; behavioral and psychological symptoms of dementia; beta-amyloid; cerebrospinal fluid; genomic profiling; mild cognitive impairment; magnetic resonance imaging; monoaminergic systems; proteomics; tau protein)

Sažetak
This large-scale 3-year project (2012-2014) is designed to determine the diagnostic accuracy of potentially useful biological markers for discrimination among subjects with Alzheimer's disease (AD), mild cognitive impairment (MCI), non-demented healthy controls (HC), and patients with other primary causes of dementia. Preliminary findings obtained on 69 AD, 41 MCI, and 10 HC cases will be presented. As AD and other less prevalent primary causes of dementia have overlapping clinical features, our first goal is to improve the distinction between these two groups using biomarkers in cerebrospinal fluid (total tau and various phospho-tau proteins, but also glycosphingolipids and other promising molecules) and by using brain imaging, as proposed by the 2010 ESFN guidelines. Second, we will follow-up patients with early behavioral and psychological symptoms of dementia (BPSD) using Neuropsychiatric Inventory (NPI), Alzheimer´s Disease Assesment Scale for non-cognitive symptoms (ADAS-noncog), and behavior rating scale (BEHAVE- AD), to reveal how early non-cognitive symptoms correlate with biochemical, imaging, and genetic biomarkers that may contribute to the risk of AD. Besides gene expression profiling using RNAseq, we will also try to determine polymorphisms of select genes coding for components of monoaminergic systems, inflammation pathways, neuronal differentiation, and lipoprotein metabolism. To identify those patients most likely to benefit from therapeutic intervention, our ultimate long- term objective is to develop reliable diagnostic criteria for detection of preclinical stages of AD. Particular attention will be given to depressive symptoms to assess if treatment of depression in MCI cases may delay the onset of dementia.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti, Psihologija